417 related articles for article (PubMed ID: 8318174)
1. Presentation and course of AIDS dementia complex: 10 years of follow-up in Amsterdam, The Netherlands.
Portegies P; Enting RH; de Gans J; Algra PR; Derix MM; Lange JM; Goudsmit J
AIDS; 1993 May; 7(5):669-75. PubMed ID: 8318174
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid beta 2-microglobulin in patients with AIDS dementia complex: an expanded series including response to zidovudine treatment.
Brew BJ; Bhalla RB; Paul M; Sidtis JJ; Keilp JJ; Sadler AE; Gallardo H; McArthur JC; Schwartz MK; Price RW
AIDS; 1992 May; 6(5):461-5. PubMed ID: 1616651
[TBL] [Abstract][Full Text] [Related]
3. [Nervous system manifestations in HIV infected children].
Funk M; Joseph-Steiner J; Hernaiz-Driever P; Mentzer D; Göhlich-Ratmann G; Bollinger M; Kreuz W; Kornhuber B; Jacobi G
Klin Padiatr; 1996; 208(5):299-303. PubMed ID: 8992098
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of five randomized controlled trials comparing continuation of zidovudine versus switching to didanosine in HIV-infected individuals.
Raboud JM; Montaner JS; Rae S; Kahn J; Hammer SM; Katzenstein DA; Pavia A; Dolin R; Hughes MD; Cross A; Beltangady M; Gatell J; Dunkle L; Smaldone L
Antivir Ther; 1997 Dec; 2(4):237-47. PubMed ID: 11327443
[TBL] [Abstract][Full Text] [Related]
5. [Decrease in notifications of AIDS dementia complex in 1989-1990 in Italy: possible role of the early treatment with zidovudine].
Chiesi A; Agresti MG; Dally LG; Zaccarelli M; Tomino C; Floridia M; Vella S
Medicina (Firenze); 1990; 10(4):415-6. PubMed ID: 2099987
[TBL] [Abstract][Full Text] [Related]
6. [Risk of the development of dementia after interruption of zidovudine treatment].
Teira R; Uriarte E; Muñoz J; Uterga JM; Sádaba F; Zubero Z; Santamaría JM
Med Clin (Barc); 1998 Sep; 111(9):325-8. PubMed ID: 9810533
[TBL] [Abstract][Full Text] [Related]
7. Central nervous system involvement in human immunodeficiency virus disease. A prospective study including neurological examination, computerized tomography, and magnetic resonance imaging.
Pedersen C; Thomsen C; Arlien-Søborg P; Praestholm J; Kjaer L; Boesen F; Hansen HS; Nielsen JO
Dan Med Bull; 1991 Aug; 38(4):374-9. PubMed ID: 1914536
[TBL] [Abstract][Full Text] [Related]
8. Elevated cerebrospinal fluid neurofilament light protein concentrations predict the development of AIDS dementia complex.
Gisslen M; Hagberg L; Brew BJ; Cinque P; Price RW; Rosengren L
J Infect Dis; 2007 Jun; 195(12):1774-8. PubMed ID: 17492593
[TBL] [Abstract][Full Text] [Related]
9. Secular trends in the survival of HIV-infected homosexual men in Amsterdam and Vancouver estimated from a death-included CD4-staged Markov model.
Hendriks JC; Craib KJ; Veugelers PJ; van Druten HA; Coutinho RA; Schechter MT; van Griensven GJ
Int J Epidemiol; 2000 Jun; 29(3):565-72. PubMed ID: 10869332
[TBL] [Abstract][Full Text] [Related]
10. CSF quinolinic acid levels are determined by local HIV infection: cross-sectional analysis and modelling of dynamics following antiretroviral therapy.
Valle M; Price RW; Nilsson A; Heyes M; Verotta D
Brain; 2004 May; 127(Pt 5):1047-60. PubMed ID: 15013955
[TBL] [Abstract][Full Text] [Related]
11. Laboratory evaluations in HIV-1-associated cognitive/motor complex.
Syndulko K; Singer EJ; Nogales-Gaete J; Conrad A; Schmid P; Tourtellotte WW
Psychiatr Clin North Am; 1994 Mar; 17(1):91-123. PubMed ID: 8190671
[TBL] [Abstract][Full Text] [Related]
12. Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status.
Heyes MP; Brew BJ; Martin A; Price RW; Salazar AM; Sidtis JJ; Yergey JA; Mouradian MM; Sadler AE; Keilp J
Ann Neurol; 1991 Feb; 29(2):202-9. PubMed ID: 1826418
[TBL] [Abstract][Full Text] [Related]
13. Report on a 3-year follow-up zidovudine (AZT) treatment in a group of HIV-positive patients with congenital clotting disorders.
Sartori MT; Mares M; Zerbinati P; Stocco D; Girolami A
Haematologia (Budap); 1994; 26(1):17-27. PubMed ID: 7959371
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 RNA levels in the cerebrospinal fluid may increase owing to damage to the blood-brain barrier.
Burger DM; Boucher CA; Meenhorst PL; Kraayeveld CL; Portegies P; Mulder JW; Hoetelmans RM; Beijnen JH
Antivir Ther; 1997 Apr; 2(2):113-7. PubMed ID: 11322275
[TBL] [Abstract][Full Text] [Related]
15. Effects of zidovudine in 30 patients with mild to end-stage AIDS dementia complex.
Tozzi V; Narciso P; Galgani S; Sette P; Balestra P; Gerace C; Pau FM; Pigorini F; Volpini V; Camporiondo MP
AIDS; 1993 May; 7(5):683-92. PubMed ID: 8318176
[TBL] [Abstract][Full Text] [Related]
16. Zidovudine treatment of the AIDS dementia complex: results of a placebo-controlled trial. AIDS Clinical Trials Group.
Sidtis JJ; Gatsonis C; Price RW; Singer EJ; Collier AC; Richman DD; Hirsch MS; Schaerf FW; Fischl MA; Kieburtz K
Ann Neurol; 1993 Apr; 33(4):343-9. PubMed ID: 8489204
[TBL] [Abstract][Full Text] [Related]
17. A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age.
Chang L; Lee PL; Yiannoutsos CT; Ernst T; Marra CM; Richards T; Kolson D; Schifitto G; Jarvik JG; Miller EN; Lenkinski R; Gonzalez G; Navia BA;
Neuroimage; 2004 Dec; 23(4):1336-47. PubMed ID: 15589098
[TBL] [Abstract][Full Text] [Related]
18. [Progressive multifocal leukoencephalopathy in AIDS].
Enting RH; Portegies P; Algra PR; Valk J; Lange JM
Ned Tijdschr Geneeskd; 1992 Mar; 136(11):521-6. PubMed ID: 1552955
[TBL] [Abstract][Full Text] [Related]
19. [Zidovudine therapy in 141 patients with symptoms of HIV infection; a multicenter study].
Perenboom R; Reiss P; Danner SA; van 't Wout JW
Ned Tijdschr Geneeskd; 1990 Jan; 134(3):120-4. PubMed ID: 2405287
[TBL] [Abstract][Full Text] [Related]
20. Presumptive clinical criteria versus endoscopy in the diagnosis of Candida esophagitis at various HIV-1 disease stages.
Antinori A; Antinori A; Ammassari A; Masetti R; De Luca A; Murri R; Tamburrini E; Magistrelli P
Endoscopy; 1995 Jun; 27(5):371-6. PubMed ID: 7588351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
